- Home
- ATXS vs OFIX Comparison
ATXS vs OFIX Comparison
Compare ATXS & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- OFIX
- Stock Information
- Founded
- ATXS 2008
- OFIX 1987
- Country
- ATXS United States
- OFIX United States
- Employees
- ATXS N/A
- OFIX N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- OFIX Medical/Dental Instruments
- Sector
- ATXS Health Care
- OFIX Health Care
- Exchange
- ATXS Nasdaq
- OFIX Nasdaq
- Market Cap
- ATXS 401.2M
- OFIX 440.0M
- IPO Year
- ATXS 2015
- OFIX N/A
- Fundamental
- Price
- ATXS $4.76
- OFIX $11.25
- Analyst Decision
- ATXS Strong Buy
- OFIX Strong Buy
- Analyst Count
- ATXS 7
- OFIX 3
- Target Price
- ATXS $32.43
- OFIX $23.33
- AVG Volume (30 Days)
- ATXS 625.9K
- OFIX 504.7K
- Earning Date
- ATXS 05-13-2025
- OFIX 05-06-2025
- Dividend Yield
- ATXS N/A
- OFIX N/A
- EPS Growth
- ATXS N/A
- OFIX N/A
- EPS
- ATXS N/A
- OFIX N/A
- Revenue
- ATXS N/A
- OFIX $804,529,000.00
- Revenue This Year
- ATXS N/A
- OFIX $4.01
- Revenue Next Year
- ATXS N/A
- OFIX $6.08
- P/E Ratio
- ATXS N/A
- OFIX N/A
- Revenue Growth
- ATXS N/A
- OFIX 5.85
- 52 Week Low
- ATXS $3.56
- OFIX $10.50
- 52 Week High
- ATXS $12.92
- OFIX $20.73
- Technical
- Relative Strength Index (RSI)
- ATXS 54.89
- OFIX 31.65
- Support Level
- ATXS $3.83
- OFIX $10.95
- Resistance Level
- ATXS $4.98
- OFIX $11.72
- Average True Range (ATR)
- ATXS 0.45
- OFIX 0.39
- MACD
- ATXS 0.11
- OFIX 0.02
- Stochastic Oscillator
- ATXS 82.93
- OFIX 15.46
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.